• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个有乳腺癌家族史的家庭中与BRCA1基因内含子标记相关的新型突变-BRCA1遗传性单倍型

A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer.

作者信息

Miresmaeili Seyed Mohsen, Jafari Fatemeh

机构信息

Department of Biology, Science and Arts University, Yazd, Iran. Email:

出版信息

Asian Pac J Cancer Prev. 2019 Feb 26;20(2):611-614. doi: 10.31557/APJCP.2019.20.2.611.

DOI:10.31557/APJCP.2019.20.2.611
PMID:30806067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6897036/
Abstract

Background: Breast cancer is the most common cancer diagnosed among women, Tumor suppressor genes such as BRCA1 involved in cell cycle control and repairing of DNA damage. BRCA1 is a risk factor gene that alteration in its protein cause in susceptibility to breast or ovarian cancer. Short tandem repeat (STR) polymorphism is linked to some disease. Objective: The aim of this study was screening a new mutation in patients with familial breast cancer. Materials and Methods: In this study, 200 women with breast cancer were participated. Among the patients, 40 women suffer from familial breast cancer. After DNA extraction from peripheral blood samples, Exons 16 to 23 of BRCA1 gene directly analyzed in SSCP gel electrophoresis followed by direct sequencing. Results: After direct sequencing, a new mutation was detected in intron 17 of BRCA1 gene. Three patients of one family have a germ line intronic mutation in the BRCA1 gene (IVS17-27delA). Also, this mutation in this family is linked to a haplotype of intragenic short tandem repeat (STR) in the BRCA1 gene. Conclusion: By Screening of gene mutations can be found association of mutation and incidence of disease. Also, studying the mutation in families and finding specific hereditary patterns in that family can be effective in prognosis of disease in other family members.

摘要

背景

乳腺癌是女性中诊断出的最常见癌症。肿瘤抑制基因如BRCA1参与细胞周期控制和DNA损伤修复。BRCA1是一种风险因素基因,其蛋白质改变会导致患乳腺癌或卵巢癌的易感性。短串联重复序列(STR)多态性与某些疾病有关。目的:本研究旨在筛查家族性乳腺癌患者中的新突变。材料和方法:本研究纳入了200名乳腺癌女性患者。其中,40名女性患有家族性乳腺癌。从外周血样本中提取DNA后,对BRCA1基因的第16至23外显子进行SSCP凝胶电泳直接分析,随后进行直接测序。结果:直接测序后,在BRCA1基因的第17内含子中检测到一个新突变。一个家族的三名患者在BRCA1基因中有胚系内含子突变(IVS17 - 27delA)。此外,该家族中的这种突变与BRCA1基因内短串联重复序列(STR)的单倍型相关。结论:通过筛查基因突变可以发现突变与疾病发生率之间的关联。此外,研究家族中的突变并发现该家族特定的遗传模式对其他家族成员疾病的预后可能有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/879260d8fdc4/APJCP-20-611-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/9560bf579c71/APJCP-20-611-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/7d7844ef1f8d/APJCP-20-611-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/879260d8fdc4/APJCP-20-611-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/9560bf579c71/APJCP-20-611-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/7d7844ef1f8d/APJCP-20-611-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/6897036/879260d8fdc4/APJCP-20-611-g003.jpg

相似文献

1
A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer.一个有乳腺癌家族史的家庭中与BRCA1基因内含子标记相关的新型突变-BRCA1遗传性单倍型
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):611-614. doi: 10.31557/APJCP.2019.20.2.611.
2
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.
3
BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.乳腺癌病例中遗传性乳腺癌和/或卵巢癌综合征的BRCA1基因突变筛查:印度尼西亚的首次高分辨率DNA熔解分析
Asian Pac J Cancer Prev. 2016;17(3):1539-46. doi: 10.7314/apjcp.2016.17.3.1539.
4
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.瑞典南部遗传性乳腺癌和卵巢癌中BRCA1基因的奠基性突变
Am J Hum Genet. 1996 Mar;58(3):441-50.
5
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.特拉华州家族性胰腺癌的全州回顾性研究以及胰腺癌家族中基因突变的频率。
Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4.
6
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.BRCA1 和 BRCA2 未分类变异体及错义多态性在阿尔及利亚乳腺癌/卵巢癌家族中的研究。
Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.
7
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.中国家族性乳腺癌女性中 BRCA1 和 BRCA2 种系突变的流行情况和特征。
Breast Cancer Res Treat. 2012 Apr;132(2):421-8. doi: 10.1007/s10549-011-1596-x. Epub 2011 May 26.
8
Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.中国家族性乳腺癌/卵巢癌女性中BRCA1和BRCA2基因的新型种系突变及未分类变异
BMC Cancer. 2016 Feb 6;16:64. doi: 10.1186/s12885-016-2107-6.
9
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.家族性乳腺癌和卵巢癌综合征男性患者中的BRCA1和BRCA2突变。一项西班牙多中心研究的结果。
Fam Cancer. 2015 Dec;14(4):505-13. doi: 10.1007/s10689-015-9814-z.
10
Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.埃及的无症状乳腺癌:BRCA1 和 BRCA2 肿瘤抑制基因突变检测的作用。
J Exp Clin Cancer Res. 2010 Jun 25;29(1):82. doi: 10.1186/1756-9966-29-82.

本文引用的文献

1
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered transcript splicing.具有转录剪接改变的BRAF抑制剂耐药黑色素瘤中内含子变异的临床意义
Biomark Res. 2017 May 11;5:17. doi: 10.1186/s40364-017-0098-3. eCollection 2017.
2
E-cadherin genetic variants predict survival outcome in breast cancer patients.E-钙黏蛋白基因变异可预测乳腺癌患者的生存结果。
J Transl Med. 2016 Nov 16;14(1):320. doi: 10.1186/s12967-016-1077-4.
3
Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer.
伊朗家族性乳腺癌和卵巢癌患者BRCA1基因内标记的单倍型分析。
Int J Reprod Biomed. 2016 Apr;14(4):271-4.
4
BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.乳腺癌病例中遗传性乳腺癌和/或卵巢癌综合征的BRCA1基因突变筛查:印度尼西亚的首次高分辨率DNA熔解分析
Asian Pac J Cancer Prev. 2016;17(3):1539-46. doi: 10.7314/apjcp.2016.17.3.1539.
5
Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes.乳腺癌患者TP53基因的基因型和单倍型分析:与风险及临床结局的关联
PLoS One. 2015 Jul 30;10(7):e0134463. doi: 10.1371/journal.pone.0134463. eCollection 2015.
6
BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis.伊朗乳腺癌患者中BRCA1和BRCA2的常见突变:一项荟萃分析
Asian Pac J Cancer Prev. 2015;16(3):1219-24. doi: 10.7314/apjcp.2015.16.3.1219.
7
Breast cancer statistics, 2013.乳腺癌统计数据,2013 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.
8
Opportunities and hurdles in the treatment of BRCA1-related breast cancer.BRCA1 相关性乳腺癌治疗中的机遇与挑战。
Oncogene. 2014 Jul 17;33(29):3753-63. doi: 10.1038/onc.2013.329. Epub 2013 Aug 19.
9
Hereditary breast and ovarian cancer susceptibility genes (review).遗传性乳腺癌和卵巢癌易感基因(综述)。
Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. Epub 2013 Jun 19.
10
BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy.BRCA2 深内含子突变导致隐匿外显子激活:开辟新的预防性治疗策略。
Clin Cancer Res. 2012 Sep 15;18(18):4903-9. doi: 10.1158/1078-0432.CCR-12-1100. Epub 2012 Jul 2.